Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-24

Clinical Trial Update: Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing safety of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)
  • Toremifene (toremifene)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED